You searched for Cybin - Page 27 of 61

QualityStocksNewsBreaks – Cybin Corp. CEO Discusses Milestones, Goals and Momentum in Exciting Emerging Industry

Cybin, a life-sciences company focused on advancing psychedelic and nutraceutical-based products, today announced that its CEO, Doug Drysdale, is featured in an exclusive audio interview with NetworkNewsWire (“NNW”) – a financial news and content distribution company and one of 50+ brands in the InvestorBrandNetwork (“IBN”). During the interview, Drysdale provides insight into Cybin’s 2020 milestones, … Continue reading “QualityStocksNewsBreaks – Cybin Corp. CEO Discusses Milestones, Goals and Momentum in Exciting Emerging Industry”

QualityStocksNewsBreaks – Cybin Corp. Focused on Advancing New Products Amid Positive Research in Psychedelics

Cybin Corp., an exemplary Canada-based, life-science company focused on the development of pharmaceutical-grade psilocybin products, is at the forefront of change in an era open to exploring psychedelic treatment options where big pharma has failed. Started in the 1940s, but kiboshed in the 1960s with President Richard Nixon’s war on drugs, researchers have once again … Continue reading “QualityStocksNewsBreaks – Cybin Corp. Focused on Advancing New Products Amid Positive Research in Psychedelics”

QualityStocksNewsBreaks — Cybin Corp. Names Health-Care, M&A Expert as New Chief Executive Officer

Cybin Corp., a life-sciences company advancing psychedelic pharmaceuticals, has announced that Doug Drysdale has been appointed as CEO. With more than three decades of experience, Drysdale brings invaluable insight and expertise to his new role. In 2014 as a corporate director of a NASDAQ-listed pharmaceutical company, he led the company’s recapitalization efforts, raising an estimated … Continue reading “QualityStocksNewsBreaks — Cybin Corp. Names Health-Care, M&A Expert as New Chief Executive Officer”

Cybin Corp. at Forefront of Change in Psilocybin-Based Treatments

Company focused on furthering R&D of psilocybin-based medications Cybin believes psychedelic substances derived from mushrooms can work as boosters for brain Psilocybin shows promise for an array of mental health issues Cybin Corp. is a leading life-science company focused on psychedelic and nutraceutical products to support various psychiatric and neurological conditions. The company is engaged … Continue reading “Cybin Corp. at Forefront of Change in Psilocybin-Based Treatments”

QualityStocksNewsBreaks – Cybin Corp. Poised Amid Groundbreaking Decision to Allow Psilocybin Therapy

Cybin Corp., an exemplary Canada-based life-science company focused on the development of pharmaceutical-grade psilocybin products, appears ideally positioned to leverage a milestone moment. Canada’s Minister of Health, the Honourable Patty Hajdu, recently approved the use of psilocybin therapy in the end-of-life treatment of four Canadians battling incurable cancer (http://ibn.fm/0BUOU), and this groundbreaking decision bodes well for … Continue reading “QualityStocksNewsBreaks – Cybin Corp. Poised Amid Groundbreaking Decision to Allow Psilocybin Therapy”

QualityStocksNewsBreaks – Cybin Corp. Partners with IntelGenx to Develop Efficient Delivery Method for Pharmaceutical-Grade Psilocybin

Cybin Corp. recently announced its entry into a feasibility agreement with IntelGenx Corp., a leading drug-delivery company focused on the development and manufacturing of pharmaceutical delivery films (http://ibn.fm/TZeVy). Under the agreement, the two companies will collaborate to develop an orally dissolving, fast-acting film for the delivery of pharmaceutical-grade psilocybin. A recent article discussing this quotes Cybin’s … Continue reading “QualityStocksNewsBreaks – Cybin Corp. Partners with IntelGenx to Develop Efficient Delivery Method for Pharmaceutical-Grade Psilocybin”

Cybin Corp. Ideally Positioned as Landmark Decision Regarding Psilocybin Therapy Could Spark Increased Interest, Use

Canada’s Minister of Health approves the use of psilocybin therapy in end-of-life care of four Canadians battling incurable cancer The Decision marks first legal, medical exemptions for psilocybin use in Canada since the compound became illegal in 1974 Cybin subsidiary Serenity Life Sciences focuses on advancing R&D of psilocybin-based pharmaceutical products A ground-breaking decision by … Continue reading “Cybin Corp. Ideally Positioned as Landmark Decision Regarding Psilocybin Therapy Could Spark Increased Interest, Use”

Cybin Corp. Enters Feasibility Agreement to Develop Fast-Acting Psilocybin Film

Agreement with leading drug-delivery company outlines plans to develop fast-acting, orally dissolving film for delivery of pharmaceutical-grade psilocybin Cybin CEO notes that systemic bioavailability of film is projected to be high Cybin focused on developing fungi-derived psychedelic, medicinal products to treat mental illness, other health conditions Cybin Corp. announced that it has entered into a … Continue reading “Cybin Corp. Enters Feasibility Agreement to Develop Fast-Acting Psilocybin Film”

QualityStocksNewsBreaks — Cybin Calls Approval for Psilocybin Therapy in Palliative Care Treatment a ‘Watershed Moment’

Cybin Corp., Canada’s leading-edge mushroom life-sciences company, has noted its strong support for TheraPsil, a nonprofit coalition that advocates for legal, Special Access Programme (“SAP”) access to psilocybin therapy for palliative care of Canadians. The coalition recently announced that Federal Minister of Health Patty Hajdu has approved the use psilocybin therapy in the end-of-life care … Continue reading “QualityStocksNewsBreaks — Cybin Calls Approval for Psilocybin Therapy in Palliative Care Treatment a ‘Watershed Moment’”

QualityStocksNewsBreaks – Cybin Corp. Positioned in Shifting Trend Toward Psilocybin

Cybin Corp., Canada’s premier mushroom life-sciences company focused on advancing psychedelic and nutraceutical-based products, looks to be at the right place at the right time during a shifting trend toward psilocybin. Highlighting this shift, TheraPsil, a non-profit coalition that advocates for legal, compassionate access to psilocybin therapy for palliative Canadians, recently shared news that four … Continue reading “QualityStocksNewsBreaks – Cybin Corp. Positioned in Shifting Trend Toward Psilocybin”

Site Search

Company Search

Search Results for: Cybin